| USD billions | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.8 | 6.1 | 6.7 | 7.4 | 20.2 | 20.2 | +0.0% | |
| Cost of revenue | 6.5 | 5.7 | 5.6 | 5.1 | 5.8 | 5.8 | +0.0% | |
| Gross profit | 3.2 | 0.4 | 1.1 | 2.2 | 14.5 | 14.5 | +0.0% | |
| Research & development | 1.4 | 1.2 | 1.1 | 1.1 | 1.3 | 1.3 | +0.0% | |
| Selling, general & administrative | 0.7 | 0.6 | 0.5 | 0.6 | — | — | — | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | |
| Operating expenses | 2.0 | 2.5 | 1.5 | 3.6 | 2.1 | 2.1 | −0.8% | |
| Operating income | 1.2 | (2.0) | (0.5) | (1.4) | 12.4 | 12.4 | +0.1% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | +0.0% | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | +0.0% | |
| Other income / expense | 0.0 | 0.0 | (0.0) | (0.1) | — | — | — | |
| Pre-tax income | 1.2 | (2.0) | (0.5) | (1.5) | 13.0 | 13.0 | +0.0% | |
| Income tax | 0.2 | 0.1 | 0.2 | 0.2 | 1.6 | 1.6 | +0.0% | |
| Net income | 1.1 | (2.1) | (0.7) | (1.6) | 11.4 | 11.4 | +0.0% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | |
| EPS, basic (per share) | 7.39 | (14.88) | (4.67) | (11.32) | 77.78 | — | — | |
| EPS, diluted (per share) | 7.39 | (14.88) | (4.67) | (11.32) | 73.76 | — | — | |
| EBITDA | 1.7 | (1.5) | (0.2) | (1.3) | 12.5 | 12.5 | −0.1% | |
| Depreciation & amortization | 0.5 | 0.4 | 0.2 | 0.2 | 0.1 | 0.1 | +0.0% | |
| Weighted average shares (shares) | 144,000,000 | 144,000,000 | 144,000,000 | 145,000,000 | 147,000,000 | — | — | |
| Weighted average diluted shares (shares) | 144,000,000 | 144,000,000 | 144,000,000 | 145,000,000 | 155,000,000 | — | — | |
| Gross margin | 33.3% | 7.1% | 16.1% | 30.1% | 71.5% | 71.5% | +0.0 pts | |
| Operating margin | 12.3% | −33.4% | −7.0% | −18.7% | 61.2% | 61.3% | +0.1 pts | |
| Net margin | 10.9% | −35.2% | −10.1% | −22.3% | 56.5% | 56.5% | +0.0 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-07-03 and uses four consecutive reported quarters.
